XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 10,804 $ 26,996
Marketable securities 202,935 301,125
Accounts receivable, net of allowances and reserves of $3,475 and $2,930 as of September 30, 2023 and December 31, 2022, respectively 25,885 43,757
Deferred contract acquisition costs, current 12,327 13,136
Prepaid expenses and other current assets 6,538 6,281
Total current assets 258,489 391,295
Property and equipment, net 5,851 7,212
Operating right-of-use assets 3,312 5,606
Intangible asset, net 1,394 1,979
Deferred contract acquisition costs, non-current 15,642 17,773
Other long-term assets 1,271 1,608
Total assets 285,959 425,473
Current liabilities    
Accounts payable 2,696 4,611
Accrued and other current liabilities 16,626 18,465
Deferred revenue 66,603 83,453
Finance lease liabilities, current 345 1,554
Operating lease liabilities, current 2,692 2,648
Total current liabilities 88,962 110,731
Operating lease liabilities, non-current 3,176 5,040
Other long-term liabilities 1,302 1,741
Total liabilities 93,440 117,512
Commitments and contingencies (See Note 9)
Stockholders’ equity    
Common stock, $0.0001 par value per share; 500,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 42,595,628 and 47,554,801 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 4 5
Additional paid-in capital 488,305 562,555
Accumulated deficit (295,638) (253,727)
Accumulated other comprehensive loss (152) (872)
Total stockholders’ equity 192,519 307,961
Total liabilities and stockholders’ equity $ 285,959 $ 425,473